List of Tables
    Table 1. SGLT2 Inhibitor CAGR in Value, United States VS Global, 2017 VS 2022 VS 2028
    Table 2. SGLT2 Inhibitor Market Trends
    Table 3. SGLT2 Inhibitor Market Drivers
    Table 4. SGLT2 Inhibitor Market Challenges
    Table 5. SGLT2 Inhibitor Market Restraints
    Table 6. Global SGLT2 Inhibitor Sales by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 7. United States SGLT2 Inhibitor Sales by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 8. Global SGLT2 Inhibitor Sales by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 9. United States SGLT2 Inhibitor Sales by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 10. Top SGLT2 Inhibitor Manufacturers in Global Market, Ranking by Revenue (2021)
    Table 11. Global SGLT2 Inhibitor Revenue by Manufacturer, (US$ Million), 2017-2022
    Table 12. Global SGLT2 Inhibitor Revenue Share by Manufacturer, 2017-2022
    Table 13. Global SGLT2 Inhibitor Sales by Manufacturer, (Kg), 2017-2022
    Table 14. Global SGLT2 Inhibitor Sales Share by Manufacturer, 2017-2022
    Table 15. Global SGLT2 Inhibitor Price by Manufacturer (2017-2022) & (USD/g)
    Table 16. Global SGLT2 Inhibitor Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 17. Global SGLT2 Inhibitor by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in SGLT2 Inhibitor as of 2021)
    Table 18. Top Players of SGLT2 Inhibitor in Global Market, Headquarters and Distribution of Producing Region
    Table 19. Manufacturers SGLT2 Inhibitor Product Type
    Table 20. Date of International Manufacturers Enter into SGLT2 Inhibitor Market
    Table 21. Manufacturers Mergers & Acquisitions, Expansion Plans
    Table 22. Top SGLT2 Inhibitor Players in United States Market, Ranking by Revenue (2021)
    Table 23. United States SGLT2 Inhibitor Revenue by Players, (US$ Million), 2020, 2021 & 2022
    Table 24. United States SGLT2 Inhibitor Revenue Share by Players, 2020, 2021 & 2022
    Table 25. United States SGLT2 Inhibitor Sales by Players, (Kg), 2020, 2021 & 2022
    Table 26. United States SGLT2 Inhibitor Sales Share by Players, 2020, 2021 & 2022
    Table 27. Global SGLT2 Inhibitor Market Size by Region (US$ Million): 2017 VS 2022 VS 2028
    Table 28. Global SGLT2 Inhibitor Sales in Volume by Region (2017-2022) & (Kg)
    Table 29. Global SGLT2 Inhibitor Sales in Volume Forecast by Region (2023-2028) & (Kg)
    Table 30. Global SGLT2 Inhibitor Sales in Value by Region (2017-2022) & (US$ Million)
    Table 31. Global SGLT2 Inhibitor Sales in Value Forecast by Region (2023-2028) & (US$ Million)
    Table 32. North America SGLT2 Inhibitor Sales in Volume by Country (2017-2028) & (Kg)
    Table 33. North America SGLT2 Inhibitor Sales in Value by Country (2017-2028) & (US$ Million)
    Table 34. Asia Pacific SGLT2 Inhibitor Sales in Volume by Region (2017-2028) & (Kg)
    Table 35. Asia Pacific SGLT2 Inhibitor Sales in Value by Region (2017-2028) & (US$ Million)
    Table 36. Europe SGLT2 Inhibitor Sales in Volume by Country (2017-2028) & (Kg)
    Table 37. Europe SGLT2 Inhibitor Sales in Value by Country (2017-2028) & (US$ Million)
    Table 38. Latin America SGLT2 Inhibitor Sales in Volume by Country (2017-2028) & (Kg)
    Table 39. Latin Americaa SGLT2 Inhibitor Sales in Value by Country (2017-2028) & (US$ Million)
    Table 40. Middle East and Africa SGLT2 Inhibitor Sales in Volume by Country (2017-2028) & (Kg)
    Table 41. Middle East and Africa SGLT2 Inhibitor Sales in Value by Country (2017-2028) & (US$ Million)
    Table 42. Eli Lilly Corporation Information
    Table 43. Eli Lilly Description and Business Overview
    Table 44. Eli Lilly SGLT2 Inhibitor Sales (Kg), Revenue (US$ Million), Price (USD/g) and Gross Margin (2017-2022)
    Table 45. Eli Lilly SGLT2 Inhibitor Product
    Table 46. Eli Lilly Recent Development
    Table 47. Boehringer Ingelheim Corporation Information
    Table 48. Boehringer Ingelheim Description and Business Overview
    Table 49. Boehringer Ingelheim SGLT2 Inhibitor Sales (Kg), Revenue (US$ Million), Price (USD/g) and Gross Margin (2017-2022)
    Table 50. Boehringer Ingelheim Product
    Table 51. Boehringer Ingelheim Recent Development
    Table 52. Johnson & Johnson Corporation Information
    Table 53. Johnson & Johnson Description and Business Overview
    Table 54. Johnson & Johnson SGLT2 Inhibitor Sales (Kg), Revenue (US$ Million), Price (USD/g) and Gross Margin (2017-2022)
    Table 55. Johnson & Johnson Product
    Table 56. Johnson & Johnson Recent Development
    Table 57. AstraZeneca Corporation Information
    Table 58. AstraZeneca Description and Business Overview
    Table 59. AstraZeneca SGLT2 Inhibitor Sales (Kg), Revenue (US$ Million), Price (USD/g) and Gross Margin (2017-2022)
    Table 60. AstraZeneca Product
    Table 61. AstraZeneca Recent Development
    Table 62. Merck Corporation Information
    Table 63. Merck Description and Business Overview
    Table 64. Merck SGLT2 Inhibitor Sales (Kg), Revenue (US$ Million), Price (USD/g) and Gross Margin (2017-2022)
    Table 65. Merck Product
    Table 66. Merck Recent Development
    Table 67. Pfizer Corporation Information
    Table 68. Pfizer Description and Business Overview
    Table 69. Pfizer SGLT2 Inhibitor Sales (Kg), Revenue (US$ Million), Price (USD/g) and Gross Margin (2017-2022)
    Table 70. Pfizer Product
    Table 71. Pfizer Recent Development
    Table 72. Key Raw Materials Lists
    Table 73. Raw Materials Key Suppliers Lists
    Table 74. SGLT2 Inhibitor Customers List
    Table 75. SGLT2 Inhibitor Distributors List
    Table 76. Research Programs/Design for This Report
    Table 77. Key Data Information from Secondary Sources
    Table 78. Key Data Information from Primary Sources
List of Figures
    Figure 1. SGLT2 Inhibitor Product Picture
    Figure 2. Global SGLT2 Inhibitor Revenue, (US$ Million), 2017 VS 2022 VS 2028
    Figure 3. Global SGLT2 Inhibitor Market Size 2017-2028 (US$ Million)
    Figure 4. Global SGLT2 Inhibitor Sales 2017-2028 (Kg)
    Figure 5. United States SGLT2 Inhibitor Revenue, (US$ Million), 2017 VS 2022 VS 2028
    Figure 6. United States SGLT2 Inhibitor Market Size 2017-2028 (US$ Million)
    Figure 7. United States SGLT2 Inhibitor Sales 2017-2028 (Kg)
    Figure 8. United States SGLT2 Inhibitor Market Share in Global, in Value (US$ Million) 2017-2028
    Figure 9. United States SGLT2 Inhibitor Market Share in Global, in Volume (Kg) 2017-2028
    Figure 10. SGLT2 Inhibitor Report Years Considered
    Figure 11. Product Picture of Dapagliflozin
    Figure 12. Product Picture of Canagliflozin
    Figure 13. Product Picture of Empagliflozin
    Figure 14. Product Picture of Other
    Figure 15. Global SGLT2 Inhibitor Market Share by Type in 2022 & 2028
    Figure 16. Global SGLT2 Inhibitor Sales in Value by Type (2017-2028) & (US$ Million)
    Figure 17. Global SGLT2 Inhibitor Sales Market Share in Value by Type (2017-2028)
    Figure 18. Global SGLT2 Inhibitor Sales by Type (2017-2028) & (Kg)
    Figure 19. Global SGLT2 Inhibitor Sales Market Share in Volume by Type (2017-2028)
    Figure 20. Global SGLT2 Inhibitor Price by Type (2017-2028) & (USD/g)
    Figure 21. United States SGLT2 Inhibitor Market Share by Type in 2022 & 2028
    Figure 22. United States SGLT2 Inhibitor Sales in Value by Type (2017-2028) & (US$ Million)
    Figure 23. United States SGLT2 Inhibitor Sales Market Share in Value by Type (2017-2028)
    Figure 24. United States SGLT2 Inhibitor Sales by Type (2017-2028) & (Kg)
    Figure 25. United States SGLT2 Inhibitor Sales Market Share in Volume by Type (2017-2028)
    Figure 26. United States SGLT2 Inhibitor Price by Type (2017-2028) & (USD/g)
    Figure 27. Product Picture of Hospital Pharmacies
    Figure 28. Product Picture of Retail Pharmacies
    Figure 29. Global SGLT2 Inhibitor Market Share by Application in 2022 & 2028
    Figure 30. Global SGLT2 Inhibitor Sales in Value by Application (2017-2028) & (US$ Million)
    Figure 31. Global SGLT2 Inhibitor Sales Market Share in Value by Application (2017-2028)
    Figure 32. Global SGLT2 Inhibitor Sales by Application (2017-2028) & (Kg)
    Figure 33. Global SGLT2 Inhibitor Sales Market Share in Volume by Application (2017-2028)
    Figure 34. Global SGLT2 Inhibitor Price by Application (2017-2028) & (USD/g)
    Figure 35. United States SGLT2 Inhibitor Market Share by Application in 2022 & 2028
    Figure 36. United States SGLT2 Inhibitor Sales in Value by Application (2017-2028) & (US$ Million)
    Figure 37. United States SGLT2 Inhibitor Sales Market Share in Value by Application (2017-2028)
    Figure 38. United States SGLT2 Inhibitor Sales by Application (2017-2028) & (Kg)
    Figure 39. United States SGLT2 Inhibitor Sales Market Share in Volume by Application (2017-2028)
    Figure 40. United States SGLT2 Inhibitor Price by Application (2017-2028) & (USD/g)
    Figure 41. North America SGLT2 Inhibitor Sales in Volume Growth Rate 2017-2028 (Kg)
    Figure 42. North America SGLT2 Inhibitor Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 43. U.S. SGLT2 Inhibitor Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 44. Canada SGLT2 Inhibitor Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 45. Europe SGLT2 Inhibitor Sales in Volume Growth Rate 2017-2028 (Kg)
    Figure 46. Europe SGLT2 Inhibitor Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 47. Germany SGLT2 Inhibitor Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 48. France SGLT2 Inhibitor Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 49. U.K. SGLT2 Inhibitor Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 50. Italy SGLT2 Inhibitor Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 51. Russia SGLT2 Inhibitor Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 52. Asia-Pacific SGLT2 Inhibitor Sales in Volume Growth Rate 2017-2028 (Kg)
    Figure 53. Asia-Pacific SGLT2 Inhibitor Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 54. China SGLT2 Inhibitor Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 55. Japan SGLT2 Inhibitor Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 56. South Korea SGLT2 Inhibitor Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 57. India SGLT2 Inhibitor Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 58. Australia SGLT2 Inhibitor Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 59. Taiwan SGLT2 Inhibitor Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 60. Indonesia SGLT2 Inhibitor Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 61. Thailand SGLT2 Inhibitor Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 62. Malaysia SGLT2 Inhibitor Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 63. Philippines SGLT2 Inhibitor Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 64. Latin America SGLT2 Inhibitor Sales in Volume Growth Rate 2017-2028 (Kg)
    Figure 65. Latin America SGLT2 Inhibitor Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 66. Mexico SGLT2 Inhibitor Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 67. Brazil SGLT2 Inhibitor Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 68. Argentina SGLT2 Inhibitor Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 69. Middle East & Africa SGLT2 Inhibitor Sales in Volume Growth Rate 2017-2028 (Kg)
    Figure 70. Middle East & Africa SGLT2 Inhibitor Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 71. Turkey SGLT2 Inhibitor Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 72. Saudi Arabia SGLT2 Inhibitor Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 73. U.A.E SGLT2 Inhibitor Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 74. SGLT2 Inhibitor Value Chain
    Figure 75. SGLT2 Inhibitor Production Process
    Figure 76. Channels of Distribution
    Figure 77. Distributors Profiles
    Figure 78. Bottom-up and Top-down Approaches for This Report
    Figure 79. Data Triangulation
    Figure 80. Key Executives Interviewed